News | News By Subject | News by Disease News By Date | Search News

Lung cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Bristol-Myers Squibb (BMY) Looks Over Its Shoulder as Opdivo Disappoints While Merck & Co. (MRK)'s Keytruda Shines in Lung Cancer Study     10/10/2016
Genentech (RHHBY)’s Lung Cancer Drug Alecensa Gets 2nd FDA Breakthrough Status     10/5/2016
This Biotech Has the Upper Hand Over Allergan (AGN) and Gilead (GILD) in the Heated Nash Battle     9/23/2016
FDA Grants Priority Review and Breakthrough Tag for Merck & Co. (MRK)’s Keytruda     9/7/2016
Genentech (RHHBY)'s Tecentriq Shows Positive Data in Phase III Trial, Has an Upcoming Action Date in October     9/2/2016
Merck & Co. (MRK)'s Keytruda May Have an Edge Over Bristol-Myers Squibb (BMY)'s Opdivo for Cancer Doctors     8/26/2016
AstraZeneca PLC (AZN)'s Lung Cancer Drug Flunks Late-Stage Test     8/10/2016
Bristol-Myers Squibb (BMY)'s $4 Billion Disaster Sends Partner Ono Pharma (OPHLY)'s Stock Plunging     8/9/2016
Bristol-Myers Squibb (BMY)'s Failed Lung Cancer Data Sends Stock Plunging     8/5/2016
Boehringer Ingelheim Halts Two Phase III Trials for Lung Cancer Drug Gilotrif     7/27/2016
AbbVie (ABBV) Partners Up With Bristol-Myers Squibb (BMY) in Combo Treatment for Lung Cancer     7/25/2016
AstraZeneca PLC (AZN)'s TAGRISSO Met Primary Endpoint in Late-Stage Lung Cancer Trial     7/18/2016
GlaxoSmithKline (GSK)'s Lung Drug Passes Phase III Test     6/20/2016
Merck & Co. (MRK) Soars as Keytruda Impresses in Late-Stage Lung Cancer Study     6/16/2016
Federal Agencies Want to Know More About Clovis Oncology (CLVS)'s Rociletinib Data from Last Fall     5/13/2016

News from Around the Web
Czech Scientists Develop Human Lung Model To Aid Treatments, Brno University Of Technology Study     11/29/2016
Balance Of Power Shifts With Merck & Co. (MRK)'s Keytruda First-Line Therapy Approval In Lung Cancer     10/26/2016
Genentech (RHHBY)’s Tecentriq Wins Second Approval of the Year, This Time for Lung Cancer     10/19/2016
AI Beats Doctors At Visual Diagnosis, Observes Many Times More Lung Cancer Signals, Stanford University Study     8/19/2016
Transgenomic, Inc. (TBIO) Launches First Commercially Available CLIA Test For Detection Of EGFR C797S Mutations That Predict Resistance To 3rd Generation Kinase Therapies For Lung Cancer     7/25/2016
University of Louisville Teams Up With Company To Help Lung Cancer Diagnosis     6/15/2016
This Diet Ups Your Lung Cancer Even If You Don't Smoke, MD Anderson Cancer Center Study     3/9/2016
Biotech Startup Yihuo Bio To Produce New Device For Early Detection Of Lung Cancer     2/29/2016
Could A Lung Cancer Drug Work Better With Coke? Erasmus MC Study     2/16/2016
This Lung Cancer Drug May Not Be What It Seems, Chemists Say     1/4/2016
Study Suggests Indi's Xpresys Test Could Reduce Invasive Procedures In NSCLC Diagnosis     12/23/2015
A New Way To Test For Rejection or Infection Following Lung Transplantation, Stanford University Study     10/15/2015
Beware: Asbestos Found In Some Crayons, Toys From China     7/8/2015
Cuba Has Had A Lung Cancer Vaccine For Years     4/27/2015
Metformin May Lower Lung Cancer Risk In Diabetics, Kaiser Permanente Division Of Research Study     2/3/2015

Press Releases
Ariad (ARIA) Presents Updated Brigatinib Data With 18.4 Months Median Intracranial Progression Free Survival (PFS) In Alk+ NSCLC Patients With CNS Metastases At The World Conference On Lung Cancer     12/5/2016
Bristol-Myers Squibb (BMY) Release: Encouraging Survival Observed With Opdivo (Nivolumab) Plus Yervoy(Ipilimumab) With Longer Follow-Up In First-Line Advanced Non-Small Cell Lung Cancer, In Updated Phase 1b Checkmate -012 Study     12/5/2016
G1 Therapeutics To Evaluate Trilaciclib (G1T28) In Combination With Immune Checkpoint Inhibitor In Small-Cell Lung Cancer     12/5/2016
Menarini-Silicon Biosystems Release: DEPArray Single-Cell Isolation Technology Enables Researchers To Develop A Model For Predicting Response To Treatment In Patients With Lung Cancer     11/28/2016
Ability Pharma Initiates Phase 2 Combination Trial With ABTL0812 As First Line Therapy In Patients With Endometrial Or Squamous Lung Cancer Patients     11/22/2016
Perthera Announces Partnership With Lung Cancer Alliance To Provide No-Cost-To-Patient Precision Medicine Services Across The U.S.     11/15/2016
Boehringer Ingelheim Release: New European Study Highlights Differing Priorities In Physician’s Therapy Goals When Treating Advanced Lung Cancer Patients     11/8/2016
AbbVie (ABBV) Receives FDA Orphan Drug Designation For Investigational Medicine Veliparib For The Treatment Of Advanced Squamous Non-Small Cell Lung Cancer     11/7/2016
Roche (RHHBY) Announces FDA Approval for VENTANA PD-L1 (SP142) Assay to Support Immunotherapy Treatment Decisions In Lung Cancer     10/27/2016
Merck & Co. (MRK) Cements Lead Over Rivals After the FDA Grants Early Approval of Keytruda     10/25/2016
New Research From American Lung Association's LUNG FORCE Finds Lung Cancer Awareness Remains Critically Low, Despite Being #1 Cancer Killer     10/25/2016
Agilent Technologies Inc. (A) Receives Expanded FDA Approval For Use Of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic In Non-Small Cell Lung Cancer (NSCLC)     10/25/2016
Cantargia To Present New Data From Preclinical Studies With CAN04 In Non-Small Cell Lung Cancer     10/20/2016
OncoGenex (OGXI) Announces Results From the Phase III ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer     10/13/2016
Bristol-Myers Squibb (BMY) Release: Opdivo (nivolumab) Shows Durable Response in Longest Follow-up for a PD-1 Inhibitor in Previously Treated Advanced Non-Small Cell Lung Cancer     10/10/2016